combination of anticholinergika and glucocorticoids for the long-term treatment of asthma and copd

摘要

The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component preferably glycopymolate and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer.